High-Level Penicillin Resistance among Isolates of Enterococci
Authors:
- Julieta CalmonJCJulieta Calmon
- Clare L. CherneyCCClare L. Cherney
- Michael WendelerMWMichael Wendeler
- Peter PitsakisPPPeter Pitsakis
- James PoupardJPJames Poupard
- Matthew E. LevisonMLMatthew E. Levison
- Caroline C. JohnsonCJCaroline C. Johnson
- 1 April 1989
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 110 (7) , 515-520
Abstract
To determine the extent and clinical significance of high-level penicillin-resistant Enterococcus faecium at our institution. Surveillance of clinical enterococcal isolates, in-vitro susceptibility and timed survival studies, and determination of antibiotic efficacy in an experimental model of enterococcal endocarditis. For a 6-month period, 14% of enterococcal isolates (30 of 212) were identified as E. faecium. One third of the isolates were highly resistant to penicillin G (minimum inhibitory concentration [MIC], greater than or equal to 200 micrograms/mL) but did not produce beta-lactamase. The findings from in-vitro survival studies showed that this high-level resistance resulted in the loss of bactericidal activity normally observed when an aminoglycoside antibiotic agent is combined with penicillin. An experimental rat model of endocarditis provided in-vivo data that confirmed our in-vitro observations. After the rats received therapy for 72 hours, penicillin G either alone or in combination with gentamicin did not significantly decrease the numbers of enterococci in vegetations on heart valves compared with untreated controls (P = 0.62 and P = 0.58, respectively). Enterococcus faecium accounts for a notable proportion of clinical enterococcal isolates. Many strains from patients at our institution, as well as from patients at other institutions throughout the country, are highly resistant to penicillin. Because high-level penicillin resistance has important therapeutic implications, periodic surveillance and MIC testing of significant enterococcal isolates, especially E. faecium, are suggested.Keywords
This publication has 21 references indexed in Scilit:
- -Lactamase Production in Experimental Endocarditis Due to Aminoglycoside-Resistant Streptococcus faecalisThe Journal of Infectious Diseases, 1987
- Nosocomial Infection by Gentamicin-Resistant Streptococcus faecalisAnnals of Internal Medicine, 1987
- High-Level Resistance to Gentamicin in Streptococcus faecalis: Risk Factors and Evidence for Exogenous Acquisition of InfectionThe Journal of Infectious Diseases, 1986
- Transition from resistance to hypersusceptibility to beta-lactam antibiotics associated with loss of a low-affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillinAntimicrobial Agents and Chemotherapy, 1985
- Imipenem: First of a New Class of Beta-Lactam AntibioticsAnnals of Internal Medicine, 1985
- Streptococcus faecium outbreak in a neonatal intensive care unitJournal of Clinical Microbiology, 1984
- High-Level Resistance to Gentamicin in Clinical Isolates of EnterococciThe Journal of Infectious Diseases, 1983
- Resistance to beta-lactam antibiotics in Streptococcus faeciumAntimicrobial Agents and Chemotherapy, 1982
- Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activityAntimicrobial Agents and Chemotherapy, 1980
- Rat model of experimental endocarditisInfection and Immunity, 1978